Novartis to close Alcon deal by year-end
BASEL, Switzerland Novartis last week announced that it expects the closing of the transaction for 77% majority ownership of Alcon in late third quarter or fourth quarter of 2010.
Taking a step toward the closing, Novartis nominated five directors to replace the five Nestle nominated directors on the Alcon board. The nominees include:
- Enrico Vanni, a chemical engineer who graduated from the Federal Polytechnic School of Lausanne, Switzerland and holds a PhD from the University of Lausanne. His background also includes an MBA from INSEAD in Fontainebleau, France. Vanni managed the Geneva Office of McKinsey & Co. from 1988 to 2004. His consulting activities mostly covered companies in the pharmaceutical, consumer and finance sectors. He was head of the European pharmaceutical practice for McKinsey & Co. and served as member of the partner review committee of the firm. Since 2008, he has worked as an independent consultant and a member of several company boards of directors;
- Norman Walker earned a degree in Business Studies at the University of Brighton, U.K., in 1975 and attended the Harvard International Senior Management Program in 1994. He started his professional career with Ford Motor Co. in London, where he held a number of positions in human resources management. In 1991, Walker joined Kraft Foods and held a number of leading HR positions in Germany, the United States and Switzerland. From 1998 to 2003, he served as the Head of Corporate Human Resources of the Novartis Group;
- Paul Choffat has held a number of senior leadership and management roles across industries, including numerous years in the pharmaceutical business. He holds a J.D. from the University of Lausanne, Switzerland, and an M.B.A. from the International Institute for Management Development in Lausanne, Switzerland. He started his professional career with Nestle. From 2002 to April 2007, Choffat served as head of Novartis Consumer Health;
- Urs Baerlocher earned his J.D. from the University of Basel and was admitted to the bar in 1970. After working as a tax lawyer, he joined Sandoz, Basel, Switzerland, in 1973. Baerlocher held numerous senior leadership roles, including head of legal and tax affairs of the Novartis Group, until his retirement in summer 2007;
- Jacques Seydoux is the medical director and chair of the department of Obstetrics and Gynecology Service at the State Hospital of Jura. He graduated with an M.D. from the University of Berne, Switzerland, in 1979. Seydoux is a member of numerous professional associations, including VP of the Swiss National Obstetrics and Gynecology Society and a member of the North American Menopause Society.
Continua Health Alliance advocates eCare use at House subcommittee meeting
BEAVERTON, Ore. The Continua Health Alliance last week testified before the House Committee on Veterans Affairs Subcommittee on Health regarding the use of personal connected healthcare technologies to increase veteran access to quality health care.
Rick Cnossen, Continua president and chairman, advocated the use of eCare — a class of health information technologies that can facilitate any kind of virtual visit or electronic connectivity outside of traditional office visits — and personal connected healthcare devices that can provide lower-cost access to quality care.
“We are excited about Continua’s efforts to remove geographical barriers and provide efficient and affordable access to health care for veterans,” Cnossen said. “Personal connected health care offers many beneficial clinical capabilities, such as the ability to track vital signs and other important health data that can be shared with healthcare providers through secure systems on a regular basis, ultimately increasing the likelihood of catching health changes early and preventing illness. These are not currently available to the majority of rural-area veterans.”
Continua has made progress in the development of interoperable healthcare devices and services, but there still are barriers to integrating eCare into care plans, Cnossen noted. To ensure veterans and clinicians will receive full access to optimum health care, Continua recommended the House Committee on Veterans Affairs establish a federal organization focused on eCare, develop eCare payment reform, create blueprints for the use of eCare in states and communities, incorporate eCare as part of “meaningful use,” and make home broadband adoption for all Americans a top priority following recommendations in the FCC’s National Broadband Plan. If they are implemented, the Alliance’s recommendations will help guide the transition and adoption of eCare, making it available to U.S. veterans.
Continua Health Alliance is working to implement a system of care that enables personal connected health with an in-home or mobile broadband device that assists providers in tracking and trending healthcare data. The alliance seeks to help the nation harness the benefits of this technology to allow healthcare consumers and providers to use real-world, remotely collected data to make more informed healthcare decisions on a continual basis. This model helps empower individuals in their care, and allows caregivers to intervene as needed for more effective and efficient care.
Nipro Diagnostics names new president
FORT LAUDERDALE, Fla. Nipro has named a new president for its Nipro Diagnostics division, the company announced Thursday.
Effective immedietely, Scott Verner will be responsible for the company’s blood glucose monitoring and insulin pump business in the United States. Verner previously was SVP sales and marketing at Home Diagnostics and the newly created Nipro Diagnostics.
“I am excited to continue making contributions to building Nipro Diagnostics in my new role,” Verner said. “Our product portfolio has further evolved into a comprehensive and competitive offering, meeting a wide range of unique consumer needs and exceptionally high standards for both quality and value. We believe those standards will continue to be the basis of our growth and success over the next several years.”